The contribution of brain imaging to understanding the mechanism of second generation antipsychotic drugs.
Lyn S
LS
Pilowsky
James M
JM
Stone
D014150:Antipsychotic Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D001549:Benzamides / Q000493:pharmacokinetics; D001921:Brain / Q000187:drug effects*; D001931:Brain Mapping; D003342:Corpus Striatum / Q000187:drug effects; D065127:Dopamine D2 Receptor Antagonists; D006801:Humans; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics; D008032:Limbic System / Q000187:drug effects; D049268:Positron-Emission Tomography; D011759:Pyrrolidines / Q000493:pharmacokinetics; D050637:Receptors, Dopamine D3 / Q000037:antagonists & inhibitors*; D018967:Risperidone / Q000493:pharmacokinetics / Q000494:pharmacology*; D013702:Temporal Lobe / Q000187:drug effects; D015899:Tomography, Emission-Computed, Single-Photon
D014150:Antipsychotic Agents; D001549:Benzamides; D065127:Dopamine D2 Receptor Antagonists; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; D050637:Receptors, Dopamine D3; C063525:epidepride; D018967:Risperidone